Seneca Valley virus review highlights swine surveillance risks
Bottom line
Seneca Valley virus review underscores ongoing surveillance challenge in swine
A new review in Veterinary Sciences pulls together the latest evidence on Seneca Valley virus, also called Senecavirus A, and reinforces a familiar concern for swine health teams: the virus is still an emerging pathogen with clinical signs that can look essentially identical to foot-and-mouth disease and other vesicular foreign animal diseases. The review, published October 17, 2026, summarizes what’s known about the virus’s epidemiology, pathogenesis, diagnosis, and control, and frames SVV as a continuing biosecurity and economic issue for pig-producing countries. Outside the review, U.S. reference sources continue to stress the same point: vesicular lesions linked to SVV can trigger foreign animal disease investigations, because the disease can’t be distinguished clinically from higher-consequence transboundary threats without laboratory testing. (mdpi.com)
Why it matters: For veterinary professionals, this isn’t just a literature update. SVV remains a practical surveillance problem because even when production losses are limited in many cases, the appearance of snout or coronary band vesicles can force an urgent rule-out for foot-and-mouth disease, disrupting movement, slaughter, and diagnostics workflows. Merck notes that outbreaks have caused temporary pork plant closures while foreign animal disease incursions were excluded, and USDA training materials tell veterinarians to involve state animal health officials or APHIS when vesicular disease is suspected. The review lands as U.S. swine groups are still treating Senecavirus A as an active concern, with SHIC and AASV hosting a 2026 webinar focused on differentiating it from FMDV. (merckvetmanual.com)
What to watch: Expect continued focus on rapid diagnostics, slaughter and marketing-chain biosecurity, and whether vaccine or environmental control strategies can reduce the number of costly vesicular disease investigations tied to Senecavirus A. (ars.usda.gov)
Key facts
- Topic
- Seneca Valley virus, also called Senecavirus A
- Publication
- Veterinary Sciences review
- Publication date
- 2026-10-17
- Main concern
- Clinical signs can closely mimic foot-and-mouth disease and other vesicular foreign animal diseases
- Species
- Swine
- Clinical signs
- Vesicles or ulcerative lesions on the snout, coronary bands, and interdigital spaces
- Diagnostic issue
- It cannot be distinguished clinically from foot-and-mouth disease without laboratory testing
- Historical context
- First described in 2002; retrospective evidence suggests circulation since at least 1988
A newly published review in Veterinary Sciences argues that Seneca Valley virus, or Senecavirus A, remains an important emerging swine pathogen not because it is always highly consequential on-farm, but because its lesions can closely mimic foot-and-mouth disease and other vesicular foreign animal diseases. The paper, published October 17, 2026, synthesizes current knowledge on the virus’s biology, epidemiology, clinical presentation, diagnosis, and control, and positions SVV as a persistent biosecurity and surveillance challenge for pig-producing regions. (mdpi.com)
That framing reflects how the virus has evolved from an unusual finding to a routine differential diagnosis concern. Merck Veterinary Manual notes the virus was first described in 2002, with retrospective evidence suggesting circulation in pigs since at least 1988, but major attention followed vesicular disease events in U.S. and Brazilian swine herds in 2014 and 2015. Experimental and lesion-based evidence later helped confirm a causal relationship between SVA infection and vesicular disease, moving the field beyond simple PCR association. (merckvetmanual.com)
The practical problem is straightforward: veterinarians can’t reliably tell SVV apart from foot-and-mouth disease, swine vesicular disease, vesicular exanthema of swine, or vesicular stomatitis based on lesions alone. Merck describes typical findings as vesicles or ulcerative lesions on the snout, coronary bands, and interdigital spaces, sometimes with lameness, fever, anorexia, and lethargy. In neonatal piglets, infection has also been linked to weakness, diarrhea, neurologic signs, and elevated mortality. USDA training materials similarly emphasize that suspected vesicular disease should prompt rapid reporting and possible foreign animal disease investigation. (merckvetmanual.com)
The wider literature suggests that concern around SVA is no longer limited to isolated farm outbreaks. USDA ARS researchers reported that many U.S. vesicular disease investigations have occurred at sow slaughter plants and studied environmental contamination in lairage, including the impact of disinfection and an autogenous vaccine approach. Related published work from U.S. sow slaughter plant environments found continued SVA circulation, viable virus in some environmental samples, and two co-circulating genetic clades, underscoring the potential role of marketing channels in persistence and spread. (ars.usda.gov)
Industry and expert messaging in 2026 has echoed that concern. The Swine Health Information Center and American Association of Swine Veterinarians hosted a March 26, 2026 webinar specifically focused on Senecavirus A as an emerging disease risk in the context of FMDV preparedness, warning producers and veterinarians about the need for diligence and rapid differentiation. SHIC’s 2025 progress report, published in January 2026, described Senecavirus A as an endemic pathogen that remains an ongoing concern to the U.S. swine industry. (swinehealth.org)
Why it matters: For veterinary professionals, the review is most useful as a reminder that SVV sits at the intersection of herd health, diagnostic readiness, and regulatory response. Even if many infections are described as low production-consequence, the downstream effects of a vesicular disease investigation can be significant, including movement disruption, slaughter delays, diagnostic resource use, and heightened biosecurity costs. Merck specifically notes economic impacts tied to temporary plant closures until foreign animal disease is ruled out, while seroprevalence research has suggested stronger farm biosecurity is associated with lower odds of SVA seropositivity in breeding herds. (merckvetmanual.com)
The review also lands amid a broader research push to close gaps around persistence, transmission, and control. Recent literature has examined SVA-associated neonatal losses, host-pathogen interactions, and the durability of infection in tissues, while USDA-linked work continues to test environmental and marketing-chain interventions. For practitioners, that means SVV is less a settled disease story than an ongoing surveillance and preparedness issue, especially in systems where a single vesicular case can trigger a high-stakes foreign animal disease response. (pubmed.ncbi.nlm.nih.gov)
What to watch: The next phase will likely center on faster field-to-lab differentiation from FMD, more evidence on transmission through slaughter and transport networks, and whether biosecurity, disinfection, or vaccine strategies can materially reduce the number of SVA-linked investigations. (ars.usda.gov)
How this developed
-
Retrospective evidence suggests Seneca Valley virus was circulating in pigs by this year.
-
The virus was first described.
-
Major attention followed vesicular disease events in U.S. swine herds.
-
Major attention followed vesicular disease events in Brazilian swine herds.
-
SHIC and AASV hosted a webinar focused on Senecavirus A and FMDV preparedness.
-
The review was published in Veterinary Sciences.
Common questions
Why is Seneca Valley virus a concern for swine veterinarians?
Because its lesions can look essentially identical to foot-and-mouth disease and other vesicular foreign animal diseases, which can trigger urgent investigations and disrupt movement, slaughter, and diagnostics.What signs can Seneca Valley virus cause in pigs?
Typical findings include vesicles or ulcerative lesions on the snout, coronary bands, and interdigital spaces, sometimes with lameness, fever, anorexia, and lethargy.Can Seneca Valley virus be diagnosed by appearance alone?
No. The article says it cannot be distinguished clinically from foot-and-mouth disease without laboratory testing.What should happen if vesicular disease is suspected?
USDA training materials say veterinarians should report rapidly and involve state animal health officials or APHIS when vesicular disease is suspected.